AstraZeneca Australia presents CALOR study findings
The study links type 2 diabetes to compounded cardiorenal risks, supporting earlier disease management across the US, UK and Japan.
See the latest news and media coverage for AstraZeneca Australia. We track all announcements, press releases, and industry mentions in real time, all in one place.
Science-led biopharmaceutical company
astrazeneca.com.auLast updated
In short: AstraZeneca Australia faced drug discontinuations, COVID vaccine withdrawal, regulatory approvals, and major strategic investments.
The study links type 2 diabetes to compounded cardiorenal risks, supporting earlier disease management across the US, UK and Japan.
The company partners with NGOs to prevent chronic diseases, address climate impacts, and reach 10 million young people by 2030.
This free tool helps clinicians estimate the environmental footprint of patient care pathways to support decarbonization efforts.
Replacing non-recyclable PVC-Aluminium blister packs to improve circularity. The team will showcase these innovations at Climate Week NYC next week.
The investment will give AstraZeneca rights equivalent to approximately 12.0% of Summit’s outstanding common stock, or 10.6% on a fully diluted basis. AstraZeneca will purchase...
AstraZeneca's breast cancer pill failed to meet the main goal of improving progression-free survival in a late-stage trial, the company said on Friday, a week...
In a significant patent skirmish for the Australian biotech and pharmaceutical sector, AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) has secured a Federal Court ruling that blocks local...
The biopharmaceutical company AstraZeneca announced it will $50 billion into the United States, with...
Track AstraZeneca Australia and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to AstraZeneca Australia and other trending companies.